2023 Nhàn N.T.T., Yamada T, & Yamada K.H. Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions. International Journal of Molecular Sciences.

​

2023 Nhàn N.T.T., Maidana D.E., & Yamada K.H., Ocular Delivery of Therapeutic Agents by Cell-Penetrating Peptides. Cells.

​

2023 Cho H.D, Nhàn N.T.T., Zhou C., Tu K., Nguyen T, Sarich N.A., & Yamada K.H., KIF13B mediates VEGFR2 recycling to modulate vascular permeability. Cellular and Molecular Life Sciences.

​

2022 Yamada K.H., A novel approach in preventing vascular leakage and angiogenesis in wet age-related macular degeneration. Neural Regeneration Research.

​

2021 Waters S. B., Dominguez J.R., Cho H.D., Sarich N.A., Malik A. B. , & Yamada K. H. KIF13B-mediated VEGFR2 Trafficking is Essential for Vascular Leakage and Metastasis in vivo.  Life Science Alliance 

​

2021 Waters S. B., Zhou C., Nguyen T., Zelkha R., Lee H., Kazlauskas A., Rosenblatt M. I. , Malik A. B. , & Yamada K. H. VEGFR2 Trafficking by KIF13B Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration.
Invest Ophthalmol Vis Sci. 

​

2017   Yamada, K. H., Kang, H., & Malik, A. B. Antiangiogenic Therapeutic Potential of Peptides Derived from the Molecular Motor KIF13B that Transports VEGFR2 to Plasmalemma in Endothelial Cells. Am J Pathol.

​

2014   Yamada, K. H., Nakajima, Y., Geyer, M., Wary, K. K., Ushio-Fukai, M., Komarova, Y., & Malik, A. B. KIF13B Regulates Angiogenesis through Golgi-Plasma Membrane Trafficking of VEGFR2. J. Cell Sci

​

2012   Yamada, K.H., Kozlowski, D.A., Seidl, S.E., Lance, S., Wieschhaus, A.J., Sundivakkam, P., Tiruppathi, C., Chishti, I., Herman, I.M., Kuchay, S.M., & Chishti, A.H. Targeted gene inactivation of calpain-1 suppresses cortical degeneration due to traumatic brain injury and neuronal apoptosis induced by oxidative stress. J. Biol. Chem.

 

2010  Tong, Y., Tempel, W., Wang, H., Yamada, K., Shen, L., Senisterra, G. A., MacKenzie, F., Chishti, A. H., & Park, H. W. Phosphorylation-independent binding specificity of the KIF13-FHA domain mediates phosphoinositide transport. Proc. Nat. Acad. Sci.

​

2007   Yamada, K. H., Hanada, T., & Chishti, A. H. The effector domain of human Dlg tumor suppressor acts as a switch that relieves autoinhibition of kinesin-3 motor GAKIN/KIF13B. Biochemistry. 

 

2007   Yamada, K. H., Hanada, T., & Chishti, A. H. Transport of PIP3 by GAKIN regulates axonal determination. Protein, Nucleic Acid, and Enzyme.

 

2006   Horiguchi, K., Hanada, T., Fukui, Y., & Chishti, A. H. Transport of PIP3 by GAKIN, a kinesin-3 family protein, regulates neuronal cell polarity. J Cell Biol. 

 

1999   Tanaka, K., Horiguchi, K., Yoshida, T., Takeda, M., Fujisawa, H., Takeuchi, K., Umeda, M., Kato, S., Ihara, S., Nagata, S., & Fukui, Y. Evidence that a phosphatidylinositol 3,4,5-trisphosphate-binding protein can function in the nucleus. J Biol Chem.